Aytu BioPharma, Inc. (AYTU) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 26.49M |
| Enterprise Value | 18.28M |
| P/E Ratio | -1.8 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 0.39 |
| Price/Book Ratio | 0.73 |
| Enterprise/Revenue | 0.25 |
| Enterprise/EBITDA | -1.68 |
| Fiscal Year | June 30, 2026 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.25 |
| Operating Margin | -0.14 |
| Return On Assets | -0.14 |
| Return On Equity | -0.53 |
| Revenue | 57.57M |
| Revenue/Share | 4.67 |
| Gross Profit | 36.82M |
| EBITDA | -4.38M |
| Net Income | -14.25M |
| Diluted EPS | -1.16 |
| Total Cash | 26.31M |
| Total Cash/Share | 2.14 |
| Total Debt | 18.11M |
| Total Debt/Equity | 0.51 |
| Current Ratio | 1.13 |
| Book Value Per Share | 2.86 |
| 52-Week Change | 6.09 |
| 52-Week High | 3.07 |
| 52-Week Low | 1.8 |
| Moving Average 50 Days | 2.22 |
| Moving Average 200 Days | 2.38 |
| Average Volume | 35,260 |
| Shares Outstanding | 10.73M |
| % Held by Institutions | 36.49 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | January 06, 2023 |